Morningstar

Artisan International Value Advisor APDKX

Morningstar Medalist Rating
Medalist Rating as of | See Artisan Partners Investment Hub
  • NAV / 1-Day Return 51.92  /  −0.86 %
  • Total Assets 36.1 Bil
  • Adj. Expense Ratio
    1.120%
  • Expense Ratio 1.120%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 250,000
  • Status Limited
  • TTM Yield 1.04%
  • Turnover 19%

USD | NAV as of Oct 01, 2024 | 1-Day Return as of Oct 01, 2024, 12:42 AM GMT+0

Morningstar’s Analysis APDKX

Will APDKX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable APDKX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the APDKX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of APDKX’s parent organization’s priorities and whether they’re in line with investors’ interests.

One of the best.

Associate Director Andrew Daniels

Andrew Daniels

Associate Director

Summary

Artisan International Value is firing on all cylinders, and it retains its High People and Process ratings.

by Andrew Daniels
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings APDKX

More APDKX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 47.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

BLACKROCK T-FUND - INST SHARES FUND 30

11.23 3.8 Bil
Cash and Equivalents

Equities

10.65 3.6 Bil
—

Arch Capital Group Ltd

5.08 1.7 Bil
Financial Services

ABB Ltd

4.48 1.5 Bil
Industrials

Samsung Electronics Co Ltd

4.39 1.5 Bil
Technology

Novartis AG Registered Shares

4.39 1.5 Bil
Healthcare

Unilever PLC

4.20 1.4 Bil
Consumer Defensive

Danone SA

4.01 1.4 Bil
Consumer Defensive

UBS Group AG

3.75 1.3 Bil
Financial Services

Koninklijke Philips NV

3.29 1.1 Bil
Healthcare

Sponsor Center